Current and future trends in the prevention, treatment and control of rabies

References

• Nel LH. Vaccines for lyssaviruses other than rabies. Expert Rev. Vaccines4, 533–540 (2005).
   PubMed Web of Science ®Google Scholar
• Cliquet F, Picard-Meyer E. Rabies and rabies-related viruses: a modern perspective on an ancient disease. Rev. Sci. Tech.23, 625–642 (2004).
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation on rabies. World Health Organ. Tech. Rep. Ser.931, 1–88 (2005).
   PubMed Web of Science ®Google Scholar
• Finke S, Conzelmann KK. Replication strategies of rabies virus. Virus Res.111, 120–31 (2005).
   PubMed Web of Science ®Google Scholar
• Albertini AA, Wernimont AK, Muziol T et al. Crystal structure of the rabies virus nucleoprotein–RNA complex. Science313, 360–363 (2006).
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies. Curr. Top. Microbiol. Immunol.292, 45–56 (2005).
   PubMedGoogle Scholar
• Hellenbrand W, Meyer C, Rasch G, Steffens I, Ammon A. Cases of rabies in Germany following organ transplantation. Euro Surveill.10, E050224.6 (2005).
   PubMedGoogle Scholar
• Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. Bats: important reservoir hosts of emerging viruses. Clin. Microbiol. Rev.19, 531–545 (2006).
   PubMed Web of Science ®Google Scholar
• Lembo T, Niezgoda M, Velasco-Villa A, Cleaveland S, Ernest E, Rupprecht CE. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg. Infect. Dis.12, 310–313 (2006).
   PubMed Web of Science ®Google Scholar
• Knobel DL, Cleaveland S, Coleman PG et al. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ.83, 360–368 (2005).
   PubMed Web of Science ®Google Scholar
• Schneider MC, Belotto A, Ade MP et al. Epidemiologic situation of human rabies in Latin America in 2004. Epidemiol. Bull.26, 2–4 (2005).
   PubMedGoogle Scholar
• Meslin FX. Rabies as a traveler’s risk, especially in high-endemicity areas. J. Travel Med.12(Suppl. 1), S30–S40 (2005).
   PubMedGoogle Scholar
• CDC. Compendium of measures to prevent disease associated with animals in public settings, 2005. MMWR Morb. Mortal. Wkly Rep.54(RR04), 1–12 (2005).
   PubMedGoogle Scholar
• CDC. Human rabies prevention–United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep.48(RR-1), 1–21 (1999).
   PubMedGoogle Scholar
• Rupprecht CE. A tale of two worlds: public health management decisions in human rabies prevention. Clin. Infect. Dis.39, 281–283 (2004).
   PubMedGoogle Scholar
• Suwansrinon K, Jaijaroensup W, Wilde H, Sitprija V. Is injecting a finger with rabies immunoglobulin dangerous? Am. J. Trop. Med. Hyg.75, 363–364 (2006).
   PubMedGoogle Scholar
• Khawplod P, Wilde H, Sirikwin S et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine24(16), 3084–3086 (2006).
   PubMed Web of Science ®Google Scholar
• Hemachudha T, Mitrabhakdi E, Wilde, Vejabhuti A, Siripataravanit S, Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin. Infect Dis.28, 143–144 (1999).
   PubMed Web of Science ®Google Scholar
• Goudsmit B, Marissen WE, Weldon WC et al. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J. Infect Dis.193, 796–801 (2006).
   PubMed Web of Science ®Google Scholar
• Ko K, Koprowski H. Plant biopharming of monoclonal antibodies. Virus Res.111, 93–100 (2005).
   PubMedGoogle Scholar
• Willoughby RE, Rotar MM, Dohnau HL et al. Recovery of a patient from clinical rabies–Wisconsin, 2004. MMWR53, 1171–1173 (2005).
   Google Scholar
• Gode GR, Saksena R, Batra RK, Kalia PK, Bhide NK. Treatment of 54 clinically diagnosed rabies patients with two survivals. Indian J. Med. Res.88, 564–566 (1988).
   PubMedGoogle Scholar
• Warrell MJ, White NJ, Looareesuwan S et al. Failure of interferon α and tribavirin in rabies encephalitis. Br. Med. J.299, 830–833 (1989).
   PubMedGoogle Scholar
• Dolman CL, Charlton KM. Massive necrosis of the brain in rabies. Can. J. Neurol. Sci.14, 162–165 (1987).
   PubMedGoogle Scholar
• Willoughby RE Jr, Tieves KS, Hoffman GM et al. Survival after treatment of rabies with induction of coma. N. Engl. J. Med.352, 2508–2514 (2005).
   PubMed Web of Science ®Google Scholar
• Emmons RW, Leonard LL, DeGenaro F Jr et al. A case of human rabies with prolonged survival. Intervirology1, 60–72 (1973).
   PubMedGoogle Scholar
• Rubin RH, Sullivan L, Summers R, Gregg MB, Sikes RK. A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J. Infect Dis.122, 318–322 (1970).
   PubMedGoogle Scholar
• Bhatt DR, Hattwick MA, Gerdsen R, Emmons RW, Johnson HN. Human rabies. Diagnosis, complications, and management. Am. J. Dis. Child.127, 862–869 (1974).
   PubMedGoogle Scholar
• Torres-Anjel MJ, Volz D, Torres MJ, Turk M, Tshikuka JG. Failure to thrive, wasting syndrome, and immunodeficiency in rabies: a hypophyseal/hypothalamic/thymic axis effect of rabies virus. Rev. Infect Dis.10(Suppl. 4), S710–S725 (1988).
   PubMedGoogle Scholar
• Nylen ES, Muller B. Endocrine changes in critical illness. J. Intensive Care Med.19, 67–82 (2004).
   PubMedGoogle Scholar
• Birnbacher R, Scheibenreiter S, Blau N, Bieglmayer C, Frisch H, Waldhauser F. Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl. Pediatr. Res.43, 472–477 (1998).
   PubMedGoogle Scholar
• Schankin CJ, Birnbaum T, Linn J et al. A fatal encephalitis. Lancet365, 358 (2005).
   PubMedGoogle Scholar
• Maton PN, Pollard JD, Davis JN. Human rabies encephalomyelitis. Br. Med. J.1, 1038–1040 (1976).
   PubMedGoogle Scholar
• Jackson AC, Ye H, Phelan CC et al. Extraneural organ involvement in human rabies. Lab. Invest.79, 945–951 (1999).
   PubMed Web of Science ®Google Scholar
• Jogai S, Radotra BD, Banerjee AK. Rabies viral antigen in extracranial organs: a post-mortem study. Neuropathol. Appl. Neurobiol.28, 334–338 (2002).
   PubMedGoogle Scholar
• Hattwick MA, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies. A case report. Ann. Intern Med.76, 931–942 (1972).
   PubMed Web of Science ®Google Scholar
• Hantson P, Guerit JM, de Tourtchaninoff M et al. Rabies encephalitis mimicking the electrophysiological pattern of brain death. A case report. Eur. Neurol.33, 212–217 (1993).
   PubMedGoogle Scholar
• Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob. Agents Chemother.36, 1750–1755 (1992).
   PubMedGoogle Scholar
• Jackson AC, Warrell MJ, Rupprecht CE et al. Management of rabies in humans. Clin. Infect Dis.36, 60–63 (2003).
   PubMed Web of Science ®Google Scholar
• Bussereau F, Picard M, Blancou J, Sureau P. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol.32, 33–49 (1988).
   PubMedGoogle Scholar
• Mrak RE, Young L. Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J. Neuropathol. Exp. Neurol.53, 1–10 (1994).
   PubMedGoogle Scholar
• Hemachudha T, Sunsaneewitayakul B, Mitrabhakdi E et al. Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies. Int J. Infect Dis.7, 76–77 (2003).
   PubMedGoogle Scholar
• Tsiang H, Ceccaldi PE, Ermine A, Lockhart B, Guillemer S. Inhibition of rabies virus infection in cultured rat cortical neurons by an N-methyl-D-aspartate noncompetitive antagonist, MK-801. Antimicrob. Agents Chemother.35, 572–574 (1991).
   PubMedGoogle Scholar
• Bresink I, Danysz W, Parsons CG, Mutschler E. Different binding affinities of NMDA receptor channel blockers in various brain regions – indication of NMDA receptor heterogeneity. Neuropharmacology34, 533–540 (1995).
   PubMed Web of Science ®Google Scholar
• Porter RH, Greenamyre JT. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem.64, 614–623 (1995).
   PubMedGoogle Scholar
• de Mattos CA, de Mattos CC, Rupprecht CE. Rhabdoviruses. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 1245–1277 (2001).
   Google Scholar
• Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21–1998. A 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite. N. Engl. J. Med.339, 105–112 (1998).
   PubMedGoogle Scholar
• Powers CN, Peavy DL, Knight V. Selective inhibition of functional lymphocyte subpopulations by ribavirin. Antimicrob. Agents Chemother.22, 108–114 (1982).
   PubMedGoogle Scholar
• Tam RC, Ramasamy K, Bard J, Pai B, Lim C, Averett DR. The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels. Antimicrob. Agents Chemother.44, 1276–1283 (2000).
   PubMed Web of Science ®Google Scholar
• Lau JY, Tam RC, Liang TJ, Hong Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology35, 1002–1009 (2002).
   PubMed Web of Science ®Google Scholar
• Fekadu M. Canine Rabies. In: The Natural History of Rabies. Baer GM (Ed.), CRC Press, FL, USA, 367–378 (1991).
   Google Scholar
• Bogel K, Meslin F-X. Economics of human and canine rabies elimination: Guidelines for program orientation. Bull. WHO68, 281–291 (1990).
   PubMedGoogle Scholar
• CDC. Compendium of animal rabies prevention and control, 2006. MMWR Morb. Mortal. Wkly Rep.55(RR05), 1–8 (2006).
   PubMedGoogle Scholar
• Fearneyhough MG, Wilson PK, Clark KA et al. Results of an oral rabies vaccination program for coyotes. J. Am. Vet. Med. Assoc.212, 498–502 (1998).
   PubMed Web of Science ®Google Scholar
• Estrada R, Vos A, De Leon R, Mueller T. Field trial with oral vaccination of dogs against rabies in the Philippines. BMC Infect Dis.1, 23 (2001).
   PubMedGoogle Scholar
• Anderson SB. Wild furbearer management in eastern Canada. In: Wild Furbearer Management and Conservation in North America. Novak M, Baker JA, Obbard ME, Malloch B (Eds), OMNR, Ontario, CA, 1039–1048 (1987).
   Google Scholar
• Pybus MJ. Rabies and rabies control in striped skunks (Mephitis mephitis) in three prairie regions of western North America. J. Wildl. Dis.24, 434–449 (1988).
   PubMed Web of Science ®Google Scholar
• Connolly G. A history of toxicant ejectors in coyote control. In: Proceedings of the 20th Vertebrate Pest Conference. Timm RM, Schmidt RH (Eds), University of California, CA, USA, 201–218 (2002).
   Google Scholar
• Blancou J, Aubert MFA, Artois M. Fox Rabies. In: The Natural History of Rabies. Baer GM (Ed.), CRC Press, FL, USA, 257–290 (1991).
   Google Scholar
• Rosatte RC, Donovan D, Allan M et al. Emergency response to raccoon rabies introduction in Ontario. J. Wildl. Dis.37, 265–279 (2001).
   PubMed Web of Science ®Google Scholar
• CDC. Human death associated with bat rabies – California, 2003. MMWR Morb. Mortal. Wkly Rep.53(2), 33–35 (2004).
   PubMedGoogle Scholar
• Linhart SB, Enders RK. Some effects of diethylstilbestrol on reproduction in captive red foxes. J. Wildl. Manage.28, 358 (1964).
   Google Scholar
• US FDA. Contraception in wildlife management. In: Proceedings of a symposium on Contraception in Wildlife Management. Kreeger TJ (Ed.), US Government Printing Office, Washington DC, USA, 1–272 (1997).
   Google Scholar
• Rosatte RC, Power MJ, MacInnes CD et al. Trap-vaccinate-release and oral vaccination for rabies control in urban skunks, raccoons and foxes. J. Wildl. Dis.28, 562–571 (1992).
   PubMedGoogle Scholar
• Kemere P, Liddel MK, Evangelou P, Slate D, Osmek S. Economic analysis of a large scale oral vaccination program to control raccoon rabies. In: Human Conflicts with Wildlife: Economic Considerations. Clark L (Ed.), National Wildlife Research Center, CO, USA, 109–116 (2002).
   Google Scholar
• Krebs JW, Mondul AM, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 2000. J. Am. Vet. Med. Assoc.219(12), 1687–1699 (2001).
   PubMedGoogle Scholar
• Baer GM, Abelseth MK, Debbie JG. Oral vaccination of foxes against rabies. Am. J. Epidemiol.93, 487–490 (1971).
   PubMed Web of Science ®Google Scholar
• Steck F, Wandeler A, Bischel P et al. Oral immunization of foxes against rabies: laboratory and field studies. Comp. Immunol. Microbiol. Infect. Dis.5, 165–171 (1982).
   PubMed Web of Science ®Google Scholar
• Potzsch CJ (Ed.). Summary of rabies cases in Europe (3rd quarter 2004). Rabies Bull. Europe28(3), 4 (2004).
   Google Scholar
• MacInnes CD, Smith SM, Tinline RR et al. Elimination of rabies from red foxes in eastern Ontario. J. Wildl. Dis.37, 119–132 (2001).
   PubMedGoogle Scholar
• Rupprecht CE, Hanlon CA, Slate D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev. Biol. (Basel)119, 173–184 (2004).
   PubMedGoogle Scholar
• Slate D, Rupprecht CE, Rooney JA, Donovan D, Lein DH, Chipman RB. Status of oral rabies vaccination in wild carnivores in the United States. Virus Res.111, 68–76 (2005).
   PubMedGoogle Scholar
• Guerra MA, Curns AT, Rupprecht CE, Hanlon CA, Krebs JW, Childs JE. Skunk and raccoon rabies in the eastern United States: temporal and spatial analysis. Emerg. Inf. Dis.9, 1143–1150 (2003).
   PubMedGoogle Scholar
• Rupprecht CE, Blass L, Smith K et al. Human infection due to recombinant vaccinia-rabies glycoprotein virus. N. Engl. J. Med.345(8), 582–586 (2001).
   PubMed Web of Science ®Google Scholar
• Dietzschold B, Faber M, Schnell MJ. New approaches to the prevention and eradication of rabies. Expert Rev.Vaccines2, 399–406 (2003).
   PubMedGoogle Scholar
• Li J, Faber M, Papaneri A et al. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology356(1–2), 147–154 (2006).
   PubMedGoogle Scholar